Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a custom diet plan tame type 2 diabetes? new study tests High-Tech approach

NCT ID NCT06832059

First seen Nov 20, 2025 · Last updated Jun 23, 2026 · Updated 30 times

Summary

This pilot study tests whether giving people with type 2 diabetes personalized diet advice based on their continuous glucose monitor (CGM) readings can help them better control their blood sugar. Twenty adults with type 2 diabetes will receive either standard dietary care or a tailored plan that adjusts carbohydrate intake based on their blood sugar responses. The main goal is to see if this approach is practical and acceptable, not yet to prove it works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Steno Diabetes Center Copenhagen

    RECRUITING

    Herlev, 2730, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

personalized dietary advice guided by continuous glucose monitoring

What this could lead to

If successful, this could lead to a larger trial testing whether personalized nutrition helps people with type 2 diabetes control their blood sugar more effectively.

What could go wrong

This is a very small pilot study (20 people) testing feasibility, not effectiveness. The results may not apply to everyone with type 2 diabetes, and the approach may not work in larger, more diverse groups.

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.